Prebiotics After Autologous Stem Cell Transplant
A Pilot, Randomized, Double-blind, Placebo-controlled Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Stem Cell Transplantation in Multiple Myeloma and Lymphoma: The PRIMAL Trial
More Information
- Trial Status
- Accepting patients
- Enrollment
- 30 patients (estimated)
- Sponsors
- University of Nebraska
- Tags
- Placebo, Randomization
- Trial Type
- Supportive
- Last Update
- 11 months ago
- SparkCures ID
- 1930
- NCT Identifier
- NCT05135351
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.